AstraZeneca’s Evusheld becomes first FDA-authorized COVID antibody to protect the immunocompromised before exposurenews2021-12-08T22:40:33+00:00December 8th, 2021|Fierce Pharma|
Klick Health spreads good cheer, and $100 bills, in annual holiday video highlighting the joy of givingnews2021-12-08T22:30:25+00:00December 8th, 2021|Fierce Pharma|
As end of New York opioid trial nears, AbbVie’s Allergan ponies up $200M to settle its part of the casenews2021-12-08T19:22:50+00:00December 8th, 2021|Fierce Pharma|
ASH: Servier’s Tibsovo triumph in leukemia study primes med for combo use—and possibly Europenews2021-12-08T18:08:41+00:00December 8th, 2021|Fierce Pharma|
ASH: Bristol Myers’ Breyanzi, Gilead’s Yescarta lock horns in race to move CAR-T therapy to earlier lymphomanews2021-12-08T17:29:07+00:00December 8th, 2021|Fierce Pharma|
Pfizer, BioNTech say omicron partially evades its COVID vaccine but booster can restore protectionnews2021-12-08T16:16:53+00:00December 8th, 2021|Fierce Pharma|
Pfizer, ex-employee reach a deal in COVID-19 vaccine trade secrets casenews2021-12-08T15:34:23+00:00December 8th, 2021|Fierce Pharma|
Teligent, Edge Pharma yank meds on superpotency, sterility concernsnews2021-12-08T14:05:36+00:00December 8th, 2021|Fierce Pharma|
J&J celebrates nurses with a new campaign in wake of burnout plaguing the professionnews2021-12-08T09:10:37+00:00December 8th, 2021|Fierce Pharma|
Shkreli’s former company Vyera settles for $40M in antitrust case, but ‘pharma bro’ still faces his own trialnews2021-12-07T21:35:54+00:00December 7th, 2021|Fierce Pharma|
